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Context: Structural neuroimaging studies suggest the
presence of subtle abnormalities in the brains of pa-
tients with bipolar disorder. The influence of genetic
and/or environmental factors on these brain abnormali-
ties is unknown.
Objective: To investigate the contribution of genetic and
environmental factorsonbrainvolume inbipolardisorder.
Design: Magnetic resonance imaging (1.5 T) brain scans
of monozygotic (MZ) or dizygotic (DZ) twins concor-
dant and discordant for bipolar disorder were compared
with healthy twin pairs.
Setting: Subjects were recruited from the population,
the Netherlands Twin Register, and the twin pair cohort
at the University Medical Center Utrecht, Utrecht, The
Netherlands.
Participants: A total of 234 subjects including 50 af-
fected twin pairs (9 MZ concordant; 15 MZ discordant;
4 DZ concordant; 22 DZ discordant) and 67 healthy twin
pairs (39 MZ and 28 DZ) were included.
Main Outcome Measures: Volumes of the intracra-
nium, cerebrum, cerebellum, lateral and third ventricle, and
gray and white matter from the cerebrum and frontal, pa-
rietal, temporal, and occipital lobes, both with and with-
out correction for lithium use. To estimate the influence
of additive genetic, common, and unique environmental
factors, structural equation modeling was applied.
Results: Bipolar disorder was associated with a de-
crease in total cortical volume. Decreases in white mat-
ter were related to the genetic risk of developing bipolar
disorder (bivariate heritability,77%; 95% confidence in-
terval, 38% to 100%). Significant environmental corre-
lations were found for cortical gray matter. These rela-
tionships all became more pronounced when data were
corrected for lithium use.
Conclusions: Focusing on genes controlling white mat-
ter integrity may be a fruitful strategy in the quest to dis-
cover genes implicated in bipolar disorder. Elucidating the
mechanism by which lithium attenuates brain matter loss
may lead to the development of neuroprotective drugs.
Arch Gen Psychiatry. 2009;66(2):142-151
T HE HIGH HERITABILITY (THEpercentage of phenotypicvariance explained by ge-netic factors) of bipolar dis-order has been well docu-
mented.1 However, environmental factors
are likely to be involved as well because
the concordance rate for monozygotic
(MZ) twin pairs is only around 70%.2
The pathophysiology of bipolar disor-
der remains poorly understood, al-
though findings from structural imaging
studies suggest the presence of subtle ab-
normalities in the brains of patients with
bipolar disorder. These abnormalities in-
clude decreases in cortical volume,3-6 ce-
rebral white matter,7 cortical5,7,8 and pre-
frontal gray matter, particularly in the
subgenual and dorsolateral prefrontal cor-
tex,9 and increased ventricular vol-
umes10-14 compared with healthy sub-
jects. However, these findings are not
consistent; other studies fail to find
changes in total brain10,11,15 white5,16 and
gray matter volume,6,12,16-19 while some
studies even report increases in gray mat-
ter volume in bipolar disorder.20-22 Some
of the reported discrepancies may be ow-
ing to effects of medication, especially
lithium,22,23 or small sample sizes. De-
spite the pronounced genetic effects on
both bipolar disorder24 and brain vol-
ume,25 the question of whether the ge-
netic risk of developing bipolar disorder
is associated with some of the reported
brain abnormalities in this illness has
hardly been addressed.
Examination of the unaffected relatives
ofpatients isoftenusedtostudytherelation-
shipbetweenincreasedgeneticriskandbrain
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abnormalities because these subjects carry the genetic risk
forthediseasebutnotthedisease itself.However, thesestud-
ies are limited by the fact that they cannot discriminate ge-
neticfromsharedenvironmentalinfluence.Todate,onevolu-
metricmagnetic resonance imaging(MRI)studycompared
psychoticbipolarpatients (n=38)andtheirunaffectedrela-
tives (n=52) with healthy subjects (n=54). No differences
in volumes of the cerebrum, lateral and third ventricle, or
hippocampus were reported.26
In contrast to studies in unaffected relatives, exam-
ining MZ and dizygotic (DZ) twin pairs with at least 1
twin affected by bipolar disorder is a powerful approach
to determine the relative contribution of genetic and en-
vironmental influences. So far only 2 studies of twins have
been conducted on bipolar disorder measuring brain vol-
ume with MRI. One study included 6 MZ discordant and
6 healthy MZ twin pairs measuring the basal ganglia,
amygdala-hippocampus complex, and the cerebral hemi-
spheres. The authors concluded that genetic factors may
be associated with an increased left caudate nucleus vol-
ume.27 The second study, examining volumes of (fron-
tal and temporal) gray and white matter and ventricular
cerebrospinal fluid in 16 twin subjects with bipolar I dis-
order, 15 healthy co-twins, and 27 control twins found
decreased left white matter volume to be influenced by
familiar, possibly genetic, factors.18
In larger twin samples, a genetic model–fitting ap-
proach, also called structural equation modeling, en-
ables quantification of the relative contribution of ge-
netic and environmental influences to the possible
phenotypic correlation between bipolar disorder and brain
volume. With this method, the extent to which com-
mon genes or environmental factors influence both bi-
polar disorder and brain volume can be estimated (bi-
variate heritability).28
To quantify the genetic and environmental effects on
brain volume in bipolar disorder, we included 50 twin pairs
of whom at least 1 had bipolar disorder and 67 healthy twin
pairs (n=234), measuring global and regional (gray and
white matter) brain volumes. Because several studies have
suggested a neurotrophic or neuroprotective effect of
lithium,21,22 we also used genetic model fitting to estimate
the genetic and environmental associations after control-
ling for the possible effect of lithium on brain volumes.
METHODS
SUBJECTS
A total of 50 twin pairs affected with bipolar disorder (9 MZ con-
cordant; 15 MZ discordant; 4 DZ concordant; 22 DZ discor-
dant) were included and compared with 67 (39 MZ and 28 DZ)
healthy control twin pairs. All twins were raised together, ex-
cept for one control pair who were separated at 12 years of age
when both parents died. The subjects were between 18 and 60
years of age. Demographic information is presented in Table 1.
Clinical diagnosis of axis I psychiatric disorders was con-
firmed using the Structured Clinical Interview for DSM-IV,29
Table 1. Demographic Data
Bipolar Twin Pairs
(n=50)
Control Twin Pairs
(n=67)
MZa
(n=24)
DZb
(n=26)
MZ
(n=39)
DZ
(n=28)
Female, No. 34 34 46 31
Mean (SD) age, y 37.4 (10.6) 43.8 (8.5) 39.0 (9.9) 39.0 (7.5)
Mean (SD) parental education, y 10.9 (3.5) 11.2 (3.8) 11.3 (3.3) 11.5 (3.5)
First-degree relative, No. (%)
Bipolar disorder 8 (33) 4 (15)
Depression 4 (17) 9 (35)
Mood disorder 11 (48) 13 (50)
Bipolar
Patient
Co-twin Bipolar
Patient
Co-twin Twin 1 Twin 2 Twin 1 Twin 2
Mean (SD) education, y 11.9 (2.0) 12.0 (2.2) 13.6 (2.6) 12.3 (3.1) 13.5 (2.8) 13.8 (2.7) 13.3 (2.5) 12.6 (2.8)
First born, No. (%) 16 (48) 12 (40)
Handedness (left/right/both), No. 6/24/3 4/10/1 1/25/4 1/20/1 4/34/1 8/30/1 6/21/1 1/26/1
Mean (SD) onset age, yc 26.5 (8.9) 31.3 (9.9)
Lithium/no lithium
on day of MRI, No.d
26/7 20/10
Psychotic symptoms, No. 15 18
Mean (SD) IDS scoree 6.47 (6.7) 2.0 (2.5) 5.8 (8.3) 2.0 (2.5) 2.14 (2.9) 2.44 (2.7) 2.43 (3.9) 2.92 (2.7)
Mean (SD) YMRS score 1.1 (1.5) .50 (.82) .48 (.97) .14 (.65) .21 (.57) .13 (.34) .29 (.82) .31 (.75)
Abbreviations: BD, bipolar disorder; DZ, dizygotic; IDS, inventory of depressive symptoms (both groups below score for depressive state); MRI, magnetic
resonance imaging; MZ, monozygotic; YMRS, young mania rating scale.
aConcordant, 9; discordant, 15.
bConcordant, 4; discordant, 22.
cSignificant difference between MZ and DZ (F1,61=4.03; P=.05).
dSix patients in the bipolar patients who did not take lithium group took lithium in the past, 5 of whom had not taken lithium for at least 2 years (range, 2-8
years). One patient took lithium for 13 years and stopped 1 month before the MRI. Analyses excluding this patient did not change the results.
eSignificant difference between patients who were taking lithium and those who were not (F1,60=6.3; P=.01), but both groups were below the score for a
depressive state.
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for axis II personality disorders using the Structured Inter-
view For DSM-IV Personality,30 and for both through available
medical records (Table 2). The twin pairs had no history of
drug or alcohol dependency for the last 6 months and no se-
vere medical illness, verified with a medical history inventory.
Their current mood state was assessed using the Young Mania
Rating Scale31 and the Inventory for Depressive Symptomatol-
ogy.32 At the time of the study, all patients were euthymic, ie,
were not in a depressive, manic, or hypomanic episode, or were
in an episode in partial remission with a Young Mania Rating
Scale score of 4 or less and an Inventory for Depressive Symp-
tomatology score of 12 or less, except for 4 patients who met
criteria for a depressive episode (Inventory for Depressive Symp-
tomatology scores, 15, 20, 29, and 38, respectively).
The healthy control pairs were matched to the bipolar pairs
for zygosity, sex, age, parental education, and birth order.
Healthy control pairs had no history of axis I psychiatric dis-
order or axis II personality disorder according to DSM-IV cri-
teria (confirmed with a Structured Clinical Interview forDSM-IV
and a Structured Interview For DSM-IV Personality interview,
respectively) and no history of severe medical illness. Further-
more, they had no first-degree relative with a history of a ma-
jor axis I psychiatric disorder (DSM-IV) such as schizophre-
nia, psychotic disorder, mood disorder, anxiety disorder, or
substance-related disorder. The family histories of both the af-
fected and control twins were obtained via the Family Inter-
view Genetic Studies33 performed with both the proband and
co-twin. Zygosity was determined by DNA fingerprinting using
high polymorphic microsatellite markers 9 to 11 in the labo-
ratory of the Division Biomedical Genetics, University Medi-
cal Center Utrecht.
The study was approved by the medical ethics review board
of the University Medical Center Utrecht and all participants
gave written informed consent after full explanation of the study
aims and procedures.
MRI ACQUISITION AND IMAGE ANALYSIS
Image acquisition and data processing have been described in
previous studies from this group.34 Quantitative assessments
of the intracranium, cerebrum (total brain excluding cerebel-
lum and stem), gray and white matter of the cerebrum, lateral
and third ventricular volume, and cerebellum were performed
based on histogram analyses and series of mathematical mor-
phology operators to connect all voxels-of-interest.35,36 All im-
ages were checked after measurement and corrected manually
if necessary. To evaluate regional contributions, these gray- and
white-matter segments from the individual images were used
to identify gray and white matter for each individual lobe (fron-
tal, parietal, temporal, and occipital). A fully automated warp-
ing technique was used (Figure 1). This technique uses non-
linear transformations to register every brain scan in the study
to a model brain. The model brain was selected earlier from
200 brain images of subjects aged between 16 and 70 years.37
Frontal, parietal, temporal, and occipital lobes were manually
demarcated on this image. The borders have been described in
detail previously.38 In short, the cingulate gyrus and the insula
were excluded from all cortical segments. The prefrontal seg-
ment excluded the precentral gyrus, although a frontal seg-
ment including the precentral gyrus was also defined. The pa-
rietal segment was separated from the frontal lobe by the central
sulcus. The parietooccipital fissure defined the boundary with
the occipital lobe. The boundary between the temporal and oc-
cipital segments was defined using the temporooccipital notch.
Cortical volume is defined as the sum of the gray and white
Table 2. Lifetime Psychiatric Diagnoses of the Bipolar
Twin Pairs
No.
Index
(n=50)
Co-twins
(n=50)
Concordant
(n=13)
Discordant
(n=37)
Diagnosis
Bipolar I disorder 37 8
Bipolar II disorder 1 3
Bipolar disorder NOS 1
Bipolar disorder NOS and
schizophrenia, paranoid type
1
Major depressive disorder 4
Depressive disorder NOS 3
Schizophrenia, paranoid type 3
Dissociative disorder NOS 1
Comorbid diagnosis
Depressive disorder NOS 3
Mood disorder due
to hyperthyroidism
1
Psychotic disorder NOS 1
Psychotic disorder due to cannabis 1
Agoraphobia without history
of panic disorder
1
Panic disorder without agoraphobia 1 1
Posttraumatic stress disorder 1
Alcohol use disorder
in full remission
2 1
Cannabis use disorder
in full remission
1
Sedative use disorder 1
Sedative use disorder
in full remission
1
Anorexia nervosa 1
Borderline personality disorder 5 1
Obsessive-compulsive disorder
in full remission
1
Obsessive-compulsive
personality disorder
1
Personality disorder NOS 1 1
No diagnosis 26
Abbreviation: NOS, not otherwise specified.
Figure 1. Segmentation of lobar volumes; frontal lobe (red), parietal lobe
(blue), temporal lobe (yellow), and occipital lobe (green) (UMC Utrecht,
Department of Psychiatry, Imaging Laboratory).
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matter of the separate lobes, cortical gray matter as gray mat-
ter of all lobes, and lobar white matter as total white matter of
all lobes. Brain images were registered to the model brain using
the ANIMAL algorithm39 to remove global differences in the
sizes and shapes of the individual brains. The inverse of the
transformation process registered the manual segmentations of
the model brain to all subjects’ brain images.
STATISTICAL ANALYSIS
The main aim of the bivariate genetic model–fitting analysis was
to separate an expected correlation between bipolar disorder and
brain volume into genetic and environmental components.40,41
To estimate the relative contributions of additive genetic (A),
common environmental (C), and unique environmental (E) fac-
tors on individual differences in brain volume and the rela-
tionship with bipolar disorder, structural equation modeling
was used. The extent to which A, C, and E explained the vari-
ance in brain volumes or covariance between brain volume and
bipolar disorder was expressed as the percentage of the total
covariance and variance, resulting in estimates of, respec-
tively, h2 (heritability), c2 (common or shared environment-
ability), and e2 (unique environmentability). The factor E also
included measurement error (Figure 2).
Prior to structural equation modeling, phenotypic correla-
tions (rph) between bipolar disorder and brain volumes and cross
trait/cross twin correlations were calculated. A phenotypic cor-
relation provides information on whether the specific volume is
associated with bipolar disorder. It can result from a common set
of genes or common set of environmental factors. Phenotypic cor-
relations between bipolar disorder and brain volume were sepa-
rated into genetic (rg) and environmental components (re), thus
providing information regarding the possible shared genetic and
environmental influences of bipolar liability and brain volumes.
Separation of these sources was based on the comparison of so-
called cross-trait–cross-twin correlations for MZ and DZ twins.
The cross-trait–cross-twin correlation is the correlation between
a trait (ie, bipolar disorder) of twin 1 with another trait of twin 2
(brain volume), where twin 1 and twin 2 represent a twin pair. If
the absolute value of the correlation between brain volume of twin
1 and bipolar disorder liability of twin 2 is larger in MZ twins than
in DZ twins; this indicates that genes influencing brain volume
(partly) overlap with genes that influence bipolar disorder. The
extent of the overlap is reflected by the magnitude of the genetic
correlation (rg).
To implement these models, data were examined for out-
liers, and subsequently the residuals of the brain volumes, af-
ter regression on intracranial volume, sex, and age (SPSS ver-
BDtwin 1 BVtwin 1
0.15
ac
as es
ec
Ac Ec
MZ, 1.0; DZ, 0.5 MZ, 1.0; DZ, 0.5
As Es
 
C
1
c
C
c
0.85 
BDtwin 2 BVtwin 2
0.15
ac
as es
ec
Ac Ec As Es
 0.85 
Figure 2. Example of a path diagram of the ACE genetic model for bipolar disorder (BD) and brain volume (BV). Bivariate twin model: genetic (A) and
environmental (C/E) influences on BV and BD. The additive genetic factors (Ac and As) of monozygotic (MZ) twins are perfectly correlated (1.0), whereas those of
dizygotic (DZ) twins are correlated at 0.5. Common environmental factors shared by twins from the same family (C) are correlated at 1 for both types of twins
(only modeled for BV); the unique environmental influences (Ec and Es) are always uncorrelated between twins. Path coefficients (ac and as) quantify the effects of
genetic influences Ac and As on BV, where Ac represents genetic influences that also influence BD and As represents genetic influences that are unique for BV.
Similarly, path coefficients ec and es quantify the effect of unique environmental (Ec and Es) influences on BV. Path coefficient c quantifies the effect of common
environmental influence on BV. Genetic and environmental variance of bipolar disorder is fixed on 0.85 and 0.15.
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sion 12.0; SPSS Inc, Chicago, Illinois) were used to calculate a
5-category ordinal scale. This allowed for a bivariate (bipolar
disorder and brain volume) ordinal genetic data analysis using
the statistical package Mx42 (www.psy.vu.nl/mxbib). For or-
dinal genetic model fitting, the dichotomous variable “bipolar
disorder” was assumed to represent an underlying continuous
liability with a mean (SD) of 0 (1). A person with a high value
on the liability scale crossing a certain threshold would be scored
“patient” on our dichotomous variable, and in all other cases
considered to be healthy (discordant co-twin of patient of healthy
comparison twin pairs), thus receiving the alternative score.
The critical threshold and heritability for the underlying bipo-
lar disorder liability was not based on our sample because we
included approximately equal numbers of concordant, discor-
dant, and healthy twin pairs. We fixed prevalence and herita-
bility of bipolar disorder to the population values; prevalence
was set to 1%43,44 and heritability was set to 85%.1
Effects of genes and familial background (C) were tested by
fitting different models to the data. Parameters A, C, or both can
be removed from the basic ACE model to generate submodels (ie,
AE, CE, and E) that can be tested via likelihood ratio tests. This
likelihood ratio test statistic follows a 2 distribution. A 21 larger
than 3.84 indicates a significant difference at =.05 and indi-
cates that the discarded effect (eg, the effect of C on brain vol-
ume) cannot be left out of the model without seriously deterio-
rating the goodness of fit. The most restrictive model was accepted
as the best fitting one in case the difference between the two mod-
els was not significant.42 For relevant estimates, 95% confidence
intervals (CI) were obtained.45 For bipolar disorder, the influ-
ence of C was not implemented into the model because the lit-
erature showed no evidence of family-related (common) envi-
ronmental influences on bipolar disorder.1
The first likelihood ratio test for brain volume was whether
the influence of C on brain volumes could be discarded from the
model (see results). For the best-fitting model heritabilities and
environmentabilities (ie, percentage of total variance accounted
for by unique environmental influences, 1 hour2) of brain vol-
umes, bivariate heritabilities (the percentage of covariance be-
tween bipolar disorder and brain volume that is accounted for
by a common genetic factor: h2BV/BD=|covA| / (|covA| |covE|), where
BV is brain volume, BD is bipolar disorder, and cov is covari-
ance) and genetic and environmental correlations between bipo-
lar disorder and brain volumes were obtained.
EFFECTS OF LITHIUM
Multiple univariate analyses of variance were used to determine
if the patients who did not take lithium differ from the patients
who did take lithium in age, age at onset, educational level, manic
and depressive symptoms, number of depressive and manic epi-
sodes, number of hospitalizations, and all brain volumes, with
age, sex, and intracranial volume as covariates. A2 test was used
for the differences in sex and zygosity. A Pearson correlation was
used for all brain volumes and duration of lithium use.
After regression on intracranial volume, age, and sex, the
differences in means for the separate brain volumes between
patients who did not take lithium (L−; n=17 [for 1 patient, no
gray/white matter separation was possible]) and the patients
who took lithium (L; n=46) were calculated (Table 3). This
Table 3. Brain Volumes of Bipolar Patients, Their Co-twins, and Healthy Comparison Subjects
Mean (SD) Volume, mLa Increase, %b
Difference Between
L− and L, %e
BP
(n=63)c
Co-twinsd
(n=37)
HC
(n=134)
BP
vs HC
Co-twinsd
vs HC
Intracranium 1420 (174) 1451 (179) 1428 (129) 1.18 2.62 2.8
Cerebrum 1063 (128) 1089 (129) 1086 (111) −1.37 −0.64 −3.30 f
Gray matter 607 (69) 615 (71) 619 (70) −1.13 −0.80 −3.64
White matter 456 (77) 474 (79) 467 (66) −1.97 −0.78 −2.77
Lateral ventricle 17.1 (9.7) 16.6 (8.6) 15.2 (7.7) 8.70 4.48 12.49 f
Third ventricle .89 (.53) .84 (.41) .79 (.41) 7.7 −2.56 17.18 f
Cerebellum 138 (15) 138 (13) 141 (13) −0.72 −2.17 −2.32
Cortical volumeg 745 (92) 766 (92) 764 (80) −.47 −0.54 −3.26 f
Cortical gray matterh 447 (50) 456 (53) 458 (51) −1.45 −0.47 −3.4
Lobar white matteri 297 (52) 310 (55) 306 (39) −2.44 −1.25 −3.05
Gray matter
Prefrontal lobe 153 (18) 155 (18) 156 (18) −0.89 −0.58 −2.80
Temporal lobe 133 (14) 136 (16) 136 (14) −1.35 −0.08 −2.92
Parietal lobe 109 (12) 110 (13) 111 (13) −1.51 −1.14 −3.73
Occipital lobe 53 (8) 55 (8) 55 (8) −3.07 −0.14 −5.60
White matter
Prefrontal lobe 108 (18) 112 (19) 110 (14) −1.16 −0.23 −3.08
Temporal lobe 66 (13) 69 (14) 68 (10) −2.0 −0.97 −2.52
Parietal lobe 78 (14) 81 (14) 81 (10) −3.25 −2.56 −4.89
Occipital lobe 45 (9) 48 (10) 46 (7) −2.63 −0.04 −0.54
Abbreviations: BP, patients with bipolar disorder; HC, healthy control subjects (twin and co-twin); L, bipolar patients who are taking lithium (n=46); L−, bipolar
patients who did not take lithium (n=17).
aUncorrected for age, sex, or intracranial volume.
bCorrected for age, sex, and intracranial volume; based on a mean age of 39.04 years, mean intracranial volume of 1430 mL, and female sex.
c Including 26 patients from concordant pairs (9 monozygotic; 4 dizigotic); for one patient, no separation of gray and white matter volume was possible.
dCo-twin without bipolar disorder
eDifference obtained by subtracting L from L−.
fValues in bold face are significant at =.05.
gSum of the volumes of the prefrontal, parietal, temporal, and occipital lobes.
hSum of the volumes of the gray matter of separate lobes.
iSum of the volumes of the white matter of separate lobes.
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difference was subtracted from the values of the lithium-using
patients, resulting in an estimate of their volumes when no
lithium would have been used. After this correction, struc-
tural equation modeling was performed including all subjects,
as described in the previous paragraph. This correction for the
effects of lithium is believed to yield better estimates of the true
genetic and environmental effects on the relationship between
brain volume and bipolar disorder.
EFFECTS OF PSYCHOTIC SYMPTOMS
Multiple univariate analyses of variance were used to deter-
mine if patients with psychotic symptoms (lifetime) differ from
patients without psychotic symptoms in age, age of onset, edu-
cational level, manic and depressive symptoms, number of de-
pressive and manic episodes, or number of hospitalizations. Af-
ter genetic model fitting was performed, the volumes that were
significantly associated with bipolar disorder (rph; eTable 1 and
eTable 2; http://www.archgenpsychiatry.com) were analyzed
post hoc using multiple univariate analyses of covariance to de-
termine if these volumes were significantly different in pa-
tients with or without psychotic symptoms. Intracranial vol-
ume, age, and sex were used as covariates.
RESULTS
The demographic and clinical characteristics of all twin
pairs are presented in Table 1. Bipolar patients who were
taking lithium (L; n=46) were not significantly differ-
ent from the bipolar patients who did not take lithium
(L−; n=17) on all clinical parameters (except for current
depressive symptoms, F1,61=6.3; P=.01); when correct-
ing for multiple comparisons (Bonferroni correction), this
effect was no longer significant. In Table 3, raw mean vol-
umes and differences in brain volumes (in percentages)
are presented for bipolar patients, co-twins of patients,
and healthy comparison subjects. The differences be-
tween the volumes of L− and L bipolar patients are pre-
sented in Table 3. Multiple univariate analyses of covari-
ance showed a significant difference in cerebral (F1,58=6.8;
P=.01), cortical (F1,58=6.8; P=.01), and ventricular vol-
umes (F1,58=5,4; P=.02 for lateral ventricle and F1,58=6.8;
P=.01 for third ventricle).
There were no significant correlations between brain
volume and duration of lithium use (lithium and cere-
bral volume r= −0.04; P= .78; cerebral gray matter
r =−0.23; P=.10).
Bipolar patients without psychotic symptoms dif-
fered from bipolar patients with psychotic symptoms in
number of depressive episodes (4.25 vs 3.0 episodes;
F1,56=5.53; P=.02). All other clinical variables were not
significantly different. Brain volumes were not signifi-
cantly different between patients with and without psy-
chotic symptoms.
COMMON ENVIRONMENTAL INFLUENCE
The influence of common environment was not signifi-
cant for brain volumes. There was one exception; for
third ventricular volume, either a model containing
common environmental influences or a model contain-
ing genetic influences explained the data best. The
effects (common environment/genetic influence) could
not be discarded simultaneously from the models with-
out significantly reducing the goodness of fit
(23=26.514) and there was not enough power to distin-
guish between them. We therefore report on the AE
model for all brain volumes.
ASSOCIATION OF BRAIN VOLUME
WITH BIPOLAR DISORDER
Bipolar disorder was significantly and negatively associ-
ated with cortical volume (thesum of the gray and white
matter of all cortical lobes; phenotypic correlation,
rph=−0.14), indicating a smaller cortical volume in bi-
polar patients. Adjusted for the effect of prescribed lithium,
all brain volumes except for the cerebellum and occipi-
tal white matter were significantly associated with bipo-
lar disorder; ventricular volumes (lateral ventricle rph=
0.24; third ventricle rph= 0.29) and intracranial volume
(rph= 0.15) were positively correlated, indicating an in-
crease in these volumes in bipolar patients while all other
volumes were negatively correlated (ranging from rph=
−0.15 for temporal white matter volume to rph= −0.37 for
total cortical volume) suggesting decreases of these vol-
umes in bipolar patients (eTable 1).
COMMON GENETIC INFLUENCE ON BIPOLAR
DISORDER AND BRAIN VOLUME
Irrespective of bipolar disorder, significant moderate to
high heritabilities (h2BV) were found for brain volumes,
ranging from 54% for third ventricle volume to 93% for
intracranial volume (Table 4).
Bipolar disorder showed a genetically mediated asso-
ciation with lobar white matter. This was indicated by a
significant negative MZ cross-trait/cross-twin correlation
with bipolar disorder (−0.16) and a lower and nonsignifi-
cant DZ cross-trait–cross-twin correlation. Common genes
appear to be involved because the genetic correlation with
lobar white matter was significant (rg= −0.20), as evi-
denced by the bivariate heritability (h2BV/BD). Additive ge-
netic factors (A) were estimated to account for 77% of the
covariance (CI, 38% to 100%), indicating that at least 38%
(ie, the lower end of the CI range) of the covariance be-
tween lobar white matter and bipolar disorder liability can
be explained by common genetic factors.
After correcting for the effects of lithium, the (com-
mon) genetic influence on white matter volumes and the
risk for bipolar disorder became more pronounced; all
white matter volumes showed significant MZ cross-trait–
cross-twin correlations (eTable 2). Significant genetic cor-
relations reflecting involvement of common genes were
found for all white matter volumes (except for the oc-
cipital lobe), cerebral and total cortical volume, occipi-
tal gray matter, and third ventricular volume (rg; eTable 2).
The extent to which additive genetic factors (A) explain
the covariance between bipolar disorder and brain vol-
ume was 68% for cerebral volume, 99% for lobar white
matter, and 85% for cerebral white matter. The white mat-
ter of the separate cortical lobes contributed in almost
equal measure to this high percentage (h2BV/BD [CI];
eTable 2). Gray matter volumes did not show a signifi-
cant common genetic influence.
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UNIQUE ENVIRONMENTAL INFLUENCE
ON BIPOLAR DISORDER AND BRAIN VOLUME
First it must be noted that because the heritability of bi-
polar disorder was set to 85%, only 15% of the variance
in the underlying liability can be explained by unique en-
vironmental factors. Irrespective of disease, brain vol-
umes showed unique environmental influences ranging
from 7% for intracranial volume to 46% for third ven-
tricular volume (Table 4). Environmental correlations rep-
resent unique environmental factors associated with both
brain volume and bipolar disorder. For cortical gray mat-
ter, a significant environmental correlation was found
(re=−0.46). The bivariate environmentability (the pro-
portion of the correlation between bipolar disorder and
brain volume associated with unique environmental fac-
tors) was significant for cortical gray matter; environ-
mental influence explained 87% of the covariance be-
tween gray matter volume and bipolar disorder (CI, 34%
to 100%).
After correcting for the effects of lithium use, signifi-
cant negative environmental correlations were found for
all gray matter volumes, cerebral and cortical volume, and
cerebellar volume. Ventricular volumes were positively
correlated with bipolar disorder (re; eTable 2). The
eTable 2 (e2BV/BD) shows the extent to which unique en-
vironmental factors influence both brain volume and bi-
polar disorder (ranging from 32% for cerebral volume to
76% for prefrontal gray matter (e2BV/BD [CI]; eTable 2).
White matter volumes in bipolar disorder showed no sig-
nificant environmental influences.
COMMENT
We examined the relative contributions of genetic and
environmental influences on brain volume in bipolar dis-
order. Gray and white matter and ventricular volumes
were measured in 50 twin pairs with bipolar disorder and
67 healthy control twin pairs. To our knowledge, this is
the first MRI study using genetic model fitting in twin
pairs discordant and concordant for bipolar disorder. The
main finding is that a decrease in white matter is related
to the genetic risk of developing bipolar disorder, while
unique environmental factors are related to a decrease
in (cortical) gray matter volume in patients with bipolar
disorder.
By applying structural equation modeling, it was dem-
onstrated that at least 38% of the covariance between white
matter volume and bipolar disorder could be explained
by genetic factors that influence both the volume of white
matter and (the risk for developing) bipolar disorder. This
indicates that genes involved in the etiology of bipolar
disorder may contribute to the white matter decreases
found in bipolar patients and in their co-twins.
In addition, a significant environmental correlation be-
tween the bipolar phenotype and cortical gray matter vol-
ume was found, with at least 34% of the covariance ex-
plained by unique environmental factors that are common
to bipolar disorder and cortical gray matter brain vol-
ume. This suggests that environmental factors unique for
each individual influence both bipolar disorder and gray
matter volume, most likely in relation to the effects of
the illness itself. Finally, lithium showed considerable ef-
fects on the brain changes found in this study, attenu-
ating the decrease in both gray and white matter. As a
consequence, findings became more pronounced, but did
not change fundamentally, when analyses were cor-
rected for lithium.
Our finding that a decrease in white matter is related
to the genetic risk of developing bipolar disorder is con-
sistent with that of a previous study in 16 bipolar twin
pairs and 15 healthy co-twins. Those results provided evi-
dence suggesting that the white matter decrease in bi-
polar disorder is genetically mediated, but owing to the
smaller number of subjects and participation of incom-
plete twin pairs, familial and genetic effects could not be
separated in that study.18
Our results build on several other lines of evidence,
such as those derived from gene expression and genetic
association studies, suggesting involvement of white mat-
ter pathology in bipolar illness. For instance, reduc-
tions in the number, size, and density of glial cells46-49 as
well as downregulation of key oligodendrocyte and my-
elination genes (including transcription factors that regu-
Table 4. Estimated Influences of Additive Genetic (h2) and Unique Environmental (e2) Factors on Brain Volume,
Irrespective of Diseasea
Brain Volumes h2BV, % (95% CI) e2BV, % (95% CI) h2BV_L,b % (95% CI) e2BV_L,b % (95% CI)
Intracranium 93 (87-96) 7 (4-13) 91 (84-95) 9 (5-16)
Cerebrum 65 (46-78) 35 (22-54) 64 (45-77) 36 (23-55)
Cerebral GM 60 (39-75) 40 (25-61) 50 (29-67) 50 (33-71)
Cerebral WM 74 (58-84) 26 (16-42) 80 (66-88) 20 (22-34)
Lateral ventriclec 65 (47-78) 35 (22-53) 65 (47-78) 35 (22-53)
Third ventriclec 54 (35-70) 46 (30-65) 60 (43-73) 40 (27-57)
Cerebellum 83 (72-90) 17 (10-18) 84 (73-90) 26 (10-27)
Total cortical volumed 70 (53-82) 30 (18-47) 69 (49-70) 31 (30-51)
Cortical GM 74 (57-84) 26 (16-43) 64 (57-84) 36 (16-43)
Lobar WM 76 (61-85) 24 (15-39) 82 (70-90) 18 (10-30)
Abbreviations: BV, brain volume; CI, confidence interval; e2, unique environmentability; GM, gray matter; h2, heritability; WM, white matter.
aAll analyses were corrected for intracranial volume, age, and sex.
bh2BV_L and e2BV_L are estimates after correction on the values of the patients who were taking lithium.
cVentricular volumes were log-transformed.
dThe sum of the volumes of the prefrontal, parietal, temporal, and occipital lobes.
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late these genes) have been reported in postmortem stud-
ies in bipolar disorder.50,51 White matter abnormalities
in the risk of developing bipolar disorder, as found in our
study, are also consistent with several of the genetic as-
sociation studies reporting changes in oligodendroglia-
related genes in patients with bipolar disorder.46,52
Interestingly, white matter pathology has also been sug-
gested to be central to the genetic risk of developing schizo-
phrenia.53 Indeed, in an earlier MRI study in twins discor-
dant for schizophrenia, we reported that white matter
decrease was associated with the increased genetic risk of
developing schizophrenia.34 Similarly, a voxel-based mor-
phometry study that included patients with schizophre-
nia, bipolar patients, and their unaffected relatives found
the genetic risk for both disorders to be associated with a
white matter decrease in the left frontal and temporopari-
etal regions.54 Results from brain imaging studies of schizo-
phrenia are consistent with those from postmortem stud-
ies reporting reductions in number, size, and density of glial
cells and downregulation of oligodendrocyte and myelina-
tion genes in schizophrenia.47,55-58
Taken together, white matter pathology may consti-
tute a common genetic risk factor for bipolar disorder
and schizophrenia. Indeed, findings from genetic asso-
ciation studies suggest considerable overlap in risk genes
for bipolar disorder and schizophrenia, particularly re-
garding oligodendrocyte- and myelin-related genes.50,52,55
Our study also revealed a significant environmental
correlation between bipolar disorder and decrease in cor-
tical gray matter volume. A decrease in gray matter in
bipolar disorder has been reported earlier,5,7,59 but find-
ings have been inconsistent.18,26 In a recent meta-
analysis of volumetric studies, a relative preservation of
almost all volumes in bipolar disorder was reported; only
the right lateral ventricle was found to be enlarged.10
Strong heterogeneity for several brain regions, hetero-
geneous samples, different imaging methods, and medi-
cation use were mentioned as possible explanatory fac-
tors for the variable results. Indeed, the fact that gray
matter decrease in bipolar disorder is an inconsistent find-
ing may be owing to the use of lithium in these patients.
Several reports have suggested a neurotrophic and neu-
roprotective effect of lithium; its use in bipolar patients
has been associated with increases in cortical gray mat-
ter21,22 and hippocampal volume.23 Interestingly, after
chronic administration of lithium, a doubling of Bcl-2 (one
of the major neuroprotective proteins) levels in cortical
layers II and III of the prefrontal cortex was demon-
strated in rats.60 It is these layers that have also been re-
ported to show changes in neuronal and glial cells in post-
mortem studies in bipolar disorder. In vivo magnetic
spectroscopy studies also support a neurotrophic effect
of lithium, finding increases of N-acetyl-aspartate lev-
els, a putative marker for neuronal viability and func-
tion, in all brain regions investigated.61 Furthermore, a
striking 0.97 correlation between lithium-induced N-
acetyl-aspartate increases and regional voxel gray mat-
ter content was observed in bipolar patients after 4 weeks
of lithium use.61 The increases in both Bcl-2 and N-acetyl-
aspartate in bipolar disorder have been interpreted as neu-
roprotective effects of lithium in response to malfunc-
tioning frontal neurons.
Our findings must be viewed in light of several meth-
odological limitations. Genetic models as used in this
study cannot determine if these findings were present
premorbidly or acquired with the passage of time. Al-
though we realize that in bipolar disorder there is some
evidence for progressive brain changes,62-64 this cross-
sectional study is not designed to address this question.
Also, this twin sample is not a population-based sample
but a selected subgroup of bipolar twins and healthy con-
trol twins in The Netherlands. Nevertheless, the whole
sample of affected twins can be considered representa-
tive, with probandwise concordance rates for bipolar dis-
order of 54% for MZ twins and 26% for DZ twins.1 This
study found no significant shared environment contri-
bution to liability to the disorder.1 By constraining the
familial environmental effect to zero, it is not possible
to estimate a shared environmental correlation. It could
be argued that our results may have optimized the ge-
netic correlation. However, the MZ cross-trait–cross-
twin correlations were more than twice as large as those
for DZ twins in this study, suggesting that shared envi-
ronmental effects are unlikely to contribute to the phe-
notypic correlations. Because two-thirds of our bipolar
patients used lithium, it cannot be ruled out that this is
a good compliance sample, having structural brain cor-
relates of their own.
Finally, this study only analyzed global brain struc-
tures in twin pairs with bipolar disorder. Future studies
should examine focal brain structures.
In conclusion, we found that white matter volume de-
crease is related to the genetic risk of developing bipolar
disorder, while environmental factors, including the ef-
fects of illness, lead to decreased cortical gray matter vol-
ume. These findings mirror those reported in studies of
schizophrenia and support the notion that the disorders
share pathophysiological processes as well as vulnerabil-
ity genes that are related to deficient myelination or ab-
normal white matter integrity. Interestingly, lithium
greatly attenuated the brain volume changes, suggest-
ing that its use may, in fact, obscure similarities in brain
pathology between bipolar disorder and schizophrenia.
Our results suggest that focusing on genes controlling
white matter integrity and function may be a fruitful strat-
egy in the quest to discover vulnerability genes for bi-
polar disorder. Elucidating the mechanisms by which
lithium attenuates brain matter loss may lead to new drugs
with neuroprotective properties.
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Correction
Error in Text. In the Original Article by King et al titled
“Development and Validation of an International Risk
Prediction Algorithm for Episodes of Major Depression
in General Practice Attendees: The PredictD Study,” pub-
lished in the December issue of the Archives (2008;
65[12]:1368-1376), an incorrect URL was given in the
“Results” and “Comment” sections for the predictD
algorithm. The algorithm can be found at http://www
.ucl.ac.uk/predict-depression.
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